Roivant Sciences Ltd.
Status: Publicly traded
Direct answer
Roivant Sciences Ltd. is publicly traded on NASDAQ under the ticker ROIV.
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as...
Can you invest in Roivant Sciences Ltd.?
Yes. Roivant Sciences Ltd. trades publicly on NASDAQ as ROIV.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Roivant Sciences Ltd.
Detailed equity research is provided by MarketSnap.